Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Cancer Supportive Care Products Market: By Cancer, By Therapeutic Area, By Distribution Channel and Geography
Cancer Supportive Care Products Market: By Cancer, By Therapeutic Area, By Distribution Channel and Geography
Cancer Supportive Care Products Market size was valued at US$ 22,214.5 million in 2023 and is poised to grow at a significant CAGR of 4.5% from 2024-2030. The global market provides a detailed overview and can be segmented by cancer, therapeutic area, distribution channel, and region. By cancer, the cancer supportive care products market has been segmented into lung cancer, liver cancer, breast cancer, leukemia, prostate cancer, ovarian cancer, and bladder cancer. By cancer, the breast cancer segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have a significant growth rate over the forecasted period due to increasing incidences of breast cancer majorly in women worldwide. By therapeutic area, the cancer supportive care products market has been segmented into oral mucositis and dry mouth, chemotherapy-induced nausea and vomiting cancer pain, chemotherapy-induced anemia, chemotherapy-induced neutropenia, and bone metastases.
By therapeutic area, chemotherapy-induced nausea and vomiting cancer pain segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period. By distribution channel, the cancer supportive care products market has been segmented into hospital pharmacies, retail pharmacies, and compounding pharmacies. By distribution channel, the retail pharmacies segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to the high demand for cancer care products.
Cancer Supportive Care Products Market Key Development:
Study Period
2024-2030Base Year
2023CAGR
4.5%Largest Market
North AmericaFastest Growing Market
Europe
Rise in the incidence of cancer. As per the American Cancer Society, there would be 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States year 2019. Furthermore, Increasing the aging population leads to a cancer patient population, which increases the demand for cancer-supportive care products. According to a retrospective cohort study published in August 2020 in JAMA Network, Open titled "association of geriatric management and 90-Day postoperative mortality among patients aged 75 years and older with cancer," geriatric co-management was associated with significantly lower 90-day postoperative mortality among older cancer patients.
North America dominates the cancer supportive care products market owing to the rise in biosimilars due to the double average price of biologics. Furthermore, a rise in the research and development of pharmaceutical drugs will further propel the growth of the cancer-supportive care products market in the region over the forecasted period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 22,214.5 million |
|
Market CAGR |
4.5% |
|
By Cancer |
|
|
By Therapeutic Area |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The Cancer Supportive Care Products Market size was valued at US$ 22,214.5 million in 2023
The Cancer Supportive Care Products Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Cancer Supportive Care Products Market key players Abbott Laboratories (U.S.), Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (U.S.), Arquer Diagnostics Ltd. (U.K.), Illumina, Inc. (U.S.), Qiagen (Germany), Agilent Technologies (U.S.), Merck & Co. Inc. (U.S.), Becton Dickinson and Company (U.S.), Hologic Inc. (U.S.)
| 1.Executive Summary |
| 2.Global Cancer Supportive Care Products Market Introduction |
| 2.1.Global Cancer Supportive Care Products Market - Taxonomy |
| 2.2.Global Cancer Supportive Care Products Market - Definitions |
| 2.2.1.Cancer |
| 2.2.2.Therapeutic Area |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3.Global Cancer Supportive Care Products Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Cancer Supportive Care Products Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Cancer Supportive Care Products Market By Cancer, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. ung Cancer |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Liver Cancer |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Breast Cancer |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Leukemia |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Prostate Cancer |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Ovarian Cancer |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Bladder Cancer |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Others |
| 5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6.Global Cancer Supportive Care Products Market By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Oral Mucositis |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Dry Mouth |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Chemotherapy Induced Nausea |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Vomiting Cancer Pain |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Chemotherapy Induced Anemia |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Chemotherapy Induced Neutropenia |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Bone Metastases |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Others |
| 6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7.Global Cancer Supportive Care Products Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospital Pharmacies |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Retail Pharmacies |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Compounding Pharmacies |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Cancer Supportive Care Products Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Cancer Supportive Care Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Cancer Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.ung Cancer |
| 9.1.2.Liver Cancer |
| 9.1.3.Breast Cancer |
| 9.1.4.Leukemia |
| 9.1.5.Prostate Cancer |
| 9.1.6.Ovarian Cancer |
| 9.1.7.Bladder Cancer |
| 9.1.8.Others |
| 9.2. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oral Mucositis |
| 9.2.2.Dry Mouth |
| 9.2.3.Chemotherapy Induced Nausea |
| 9.2.4.Vomiting Cancer Pain |
| 9.2.5.Chemotherapy Induced Anemia |
| 9.2.6.Chemotherapy Induced Neutropenia |
| 9.2.7.Bone Metastases |
| 9.2.8.Others |
| 9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital Pharmacies |
| 9.3.2.Retail Pharmacies |
| 9.3.3.Compounding Pharmacies |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Cancer Supportive Care Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Cancer Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.ung Cancer |
| 10.1.2.Liver Cancer |
| 10.1.3.Breast Cancer |
| 10.1.4.Leukemia |
| 10.1.5.Prostate Cancer |
| 10.1.6.Ovarian Cancer |
| 10.1.7.Bladder Cancer |
| 10.1.8.Others |
| 10.2. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral Mucositis |
| 10.2.2.Dry Mouth |
| 10.2.3.Chemotherapy Induced Nausea |
| 10.2.4.Vomiting Cancer Pain |
| 10.2.5.Chemotherapy Induced Anemia |
| 10.2.6.Chemotherapy Induced Neutropenia |
| 10.2.7.Bone Metastases |
| 10.2.8.Others |
| 10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital Pharmacies |
| 10.3.2.Retail Pharmacies |
| 10.3.3.Compounding Pharmacies |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Cancer Supportive Care Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Cancer Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.ung Cancer |
| 11.1.2.Liver Cancer |
| 11.1.3.Breast Cancer |
| 11.1.4.Leukemia |
| 11.1.5.Prostate Cancer |
| 11.1.6.Ovarian Cancer |
| 11.1.7.Bladder Cancer |
| 11.1.8.Others |
| 11.2. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral Mucositis |
| 11.2.2.Dry Mouth |
| 11.2.3.Chemotherapy Induced Nausea |
| 11.2.4.Vomiting Cancer Pain |
| 11.2.5.Chemotherapy Induced Anemia |
| 11.2.6.Chemotherapy Induced Neutropenia |
| 11.2.7.Bone Metastases |
| 11.2.8.Others |
| 11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital Pharmacies |
| 11.3.2.Retail Pharmacies |
| 11.3.3.Compounding Pharmacies |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Cancer Supportive Care Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Cancer Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.ung Cancer |
| 12.1.2.Liver Cancer |
| 12.1.3.Breast Cancer |
| 12.1.4.Leukemia |
| 12.1.5.Prostate Cancer |
| 12.1.6.Ovarian Cancer |
| 12.1.7.Bladder Cancer |
| 12.1.8.Others |
| 12.2. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral Mucositis |
| 12.2.2.Dry Mouth |
| 12.2.3.Chemotherapy Induced Nausea |
| 12.2.4.Vomiting Cancer Pain |
| 12.2.5.Chemotherapy Induced Anemia |
| 12.2.6.Chemotherapy Induced Neutropenia |
| 12.2.7.Bone Metastases |
| 12.2.8.Others |
| 12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital Pharmacies |
| 12.3.2.Retail Pharmacies |
| 12.3.3.Compounding Pharmacies |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Cancer Supportive Care Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Cancer Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.ung Cancer |
| 13.1.2.Liver Cancer |
| 13.1.3.Breast Cancer |
| 13.1.4.Leukemia |
| 13.1.5.Prostate Cancer |
| 13.1.6.Ovarian Cancer |
| 13.1.7.Bladder Cancer |
| 13.1.8.Others |
| 13.2. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral Mucositis |
| 13.2.2.Dry Mouth |
| 13.2.3.Chemotherapy Induced Nausea |
| 13.2.4.Vomiting Cancer Pain |
| 13.2.5.Chemotherapy Induced Anemia |
| 13.2.6.Chemotherapy Induced Neutropenia |
| 13.2.7.Bone Metastases |
| 13.2.8.Others |
| 13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital Pharmacies |
| 13.3.2.Retail Pharmacies |
| 13.3.3.Compounding Pharmacies |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott Laboratories (U.S) |
| 14.2.2.Hoffmann-La Roche Ltd (Switzerland) |
| 14.2.3.AbbVie Inc (U.S) |
| 14.2.4.Arquer Diagnostics Ltd (U.K) |
| 14.2.5.Illumina Inc (U.S) |
| 14.2.6.Qiagen (Germany) |
| 14.2.7.Agilent Technologies (U.S) |
| 14.2.8.Merck & Co Inc (U.S) |
| 14.2.9.Becton Dickinson and Company (U.S) |
| 14.2.10.Hologic Inc (U.S) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.